Flu is rising rapidly across the U.S., driven by a new variant of the virus. The Centers for Disease Control and Prevention ...

Flu season is off to a rough start this year, according to new CDC data. The virus is spreading faster than in previous years ...

The new variant of Influenza A, or H3N2, has been given the nickname 'super flu.' The fast-spreading virus has caused ...

Learn more about whether Twist Bioscience Corporation or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The assay is the first to receive FDA 510(k) clearance and CLIA waiver for use with Diasorin's Liaison Nes platform.

The SD Biosensor Standard Q COVID-19 Ag Test and Acon Biotech Flowflex SARS-CoV-2 Antigen Rapid Test were previously listed under WHO's emergency use listing.

In September 2020, the SD Biosensor STANDARD Q COVID-19 Ag Test became the first rapid antigen test ever listed under WHO’s ...

WHO noted that prequalified tests can now be prioritized in pooled procurement mechanisms, which help lower prices, stabilize ...

This study systematically elucidates the drug resistance mechanisms of five highly pathogenic viruses, proposes five ...

SD Biosensor STANDARD Q and ACON Flowflex—after their earlier emergency use during the pandemic. The move confirms long-term ...

Long COVID has lingered as one of the most unsettling legacies of the pandemic, a condition that can derail lives long after ...

DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...